Literature DB >> 18849562

Anemia in cystic fibrosis: incidence, mechanisms, and association with pulmonary function and vitamin deficiency.

Annette von Drygalski1, Julie Biller.   

Abstract

BACKGROUND: Anemia is associated with increased morbidity and mortality in many chronic diseases. Little is known about anemia in cystic fibrosis (CF). Because the majority of patients with CF die of lung disease, the objective of this study was to identify the frequency, severity, and mechanisms of anemia in CF and to determine if there was an association between anemia and poor lung function in these patients. Vitamin deficiency was used to assess the association of malabsorption and anemia.
METHODS: Charts of 218 CF patients (ages >1 month to 61 years) were reviewed. Information extracted included medical history, complete blood counts, iron studies, pulmonary function tests, vitamin levels, serum creatinine levels, and medications.
RESULTS: As patients aged, anemia increased from 12% in those < 16 to 58.3% > or = age 40. Anemic patients had poorer lung function than nonanemic patients. Mean forced expiratory volume (FEV(1)) and forced vital capacity (FVC) were 51.6% (SEM +/- 10.3) and 69.7% (SEM +/- 9.3) in anemic and 82.5% (SEM +/- 9.2) and 95% (SEM +/- 8.3) in nonanemic patients, respectively (P < .001). Of vitamin-deficient patients, 90% were anemic whereas only 59.5% of nonvitamin-deficient patients were anemic (P = .02). Complete iron studies were only available in 17 of 48 anemic patients and 11 were diagnosed with iron deficiency.
CONCLUSIONS: Anemia in CF is associated with poor lung function and vitamin deficiency. Although anemia was often incompletely evaluated, iron deficiency was common. Recognition and complete evaluation of anemia might be important for continued improvement of care in CF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849562     DOI: 10.1177/0884533608323426

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  15 in total

1.  Perspectives on anemia and iron deficiency from the cystic fibrosis care community.

Authors:  Gretchen M Garlow; Lucy S Gettle; Nicola J Felicetti; Deepika Polineni; Alex H Gifford
Journal:  Pediatr Pulmonol       Date:  2019-03-28

2.  Vitamin B12-mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa.

Authors:  Kang-Mu Lee; Junhyeok Go; Mi Young Yoon; Yongjin Park; Sang Cheol Kim; Dong Eun Yong; Sang Sun Yoon
Journal:  Infect Immun       Date:  2012-02-27       Impact factor: 3.441

3.  Early severe anemia as the first sign of cystic fibrosis.

Authors:  Tugba Sismanlar; Ayşe Tana Aslan; Mehmet Köse; Sevgi Pekcan; Fatih Süheyl Ezgü; Işıl İrem Budakoğlu; İdil Yenicesu
Journal:  Eur J Pediatr       Date:  2016-08-05       Impact factor: 3.183

4.  Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.

Authors:  Alex H Gifford; Diana M Alexandru; Zhigang Li; Dana B Dorman; Lisa A Moulton; Katherine E Price; Thomas H Hampton; Mitchell L Sogin; Jonathan B Zuckerman; H Worth Parker; Bruce A Stanton; George A O'Toole
Journal:  J Cyst Fibros       Date:  2013-12-13       Impact factor: 5.482

5.  Ventilatory pattern and energy expenditure are altered in cystic fibrosis mice.

Authors:  Rebecca J Darrah; Ilya R Bederman; Anna L Mitchell; Craig A Hodges; Cara K Campanaro; Mitchell L Drumm; Frank J Jacono
Journal:  J Cyst Fibros       Date:  2013-01-03       Impact factor: 5.482

6.  Changes in Mineral Micronutrient Status During and After Pulmonary Exacerbation in Adults With Cystic Fibrosis.

Authors:  Moon Jeong Lee; Jessica A Alvarez; Ellen M Smith; David W Killilea; James F Chmiel; Patricia M Joseph; Ruth E Grossmann; Amit Gaggar; Thomas R Ziegler; Vin Tangpricha
Journal:  Nutr Clin Pract       Date:  2015-06-15       Impact factor: 3.080

7.  Iron and CF-related anemia: expanding clinical and biochemical relationships.

Authors:  A H Gifford; S D Miller; B P Jackson; T H Hampton; G A O'Toole; B A Stanton; H W Parker
Journal:  Pediatr Pulmonol       Date:  2010-10-20

8.  Safety of high-dose doripenem in adult patients with cystic fibrosis.

Authors:  Seth Strawbridge; Michael D Nailor
Journal:  Ther Adv Drug Saf       Date:  2016-04-08

9.  Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis.

Authors:  Alex H Gifford; Julie L Sanville; Meghana Sathe; Sonya L Heltshe; Christopher H Goss
Journal:  Pediatr Pulmonol       Date:  2021-04-26

10.  CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis.

Authors:  Alex H Gifford; Sonya L Heltshe; Christopher H Goss
Journal:  Ann Am Thorac Soc       Date:  2019-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.